This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Waldman, T., Lengauer, C., Kinzler, K. W. & Vogelstein, B. Nature 381, 713–716 (1996).
Lowe, S. W., Ruley, H. E., Jacks, T. & Housman, D. E. Cell 74, 957–967 (1993).
Sjögren, S. et al. J. Natl Cancer Inst. 88, 173–182 (1996).
Esrig, D. et al. N. Engl. J. Med. 331, 1259–1264 (1994).
Skinner, D. G. et al. J. Urol. 145, 459–467 (1991).
Esrig, D. et al. Am. J. Pathol. 143, 1389–1397 (1993).
Pike, M. C. J. R. Stat. Soc. A 135, 201–203 (1972).
Kaplan, E. L. & Meier, P. J. Am. Stat. Assoc. 53, 457–481 (1958).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cote, R., Esrig, D., Groshen, S. et al. p53 and treatment of bladder cancer. Nature 385, 123–124 (1997). https://doi.org/10.1038/385123b0
Issue Date:
DOI: https://doi.org/10.1038/385123b0
This article is cited by
-
Genomic Subtyping in Bladder Cancer
Current Urology Reports (2020)
-
YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage
Oncogene (2016)
-
RGD-modifided oncolytic adenovirus exhibited potent cytotoxic effect on CAR-negative bladder cancer-initiating cells
Cell Death & Disease (2015)
-
Silencing of mutant p53 by siRNA induces cell cycle arrest and apoptosis in human bladder cancer cells
World Journal of Surgical Oncology (2013)
-
Relationship between expression of apoptosis-related proteins and the efficacy of postoperative chemotherapy in patients with T3 gastric cancer
Surgery Today (2012)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.